BRASKEM PRF'A'

Braskem reported Q2/2026 adjusted earnings of $1.08 per share and revenue of $4.31bn, both below analysts' estimates ($1.27 and $4.67bn), prompting a sharp drop in the stock. Recurring EBITDA rose to $1.043bn (margin 24%), driven mainly by Brazil, which showed strong quarter-on-quarter growth. Management described the quarter as a tactical gain from higher petrochemical spreads, warned of a tougher second half of the year, and is advancing financial restructuring and cost discipline. Braskem expects further CapEx outflows, remains debt-burdened, and analysts still see challenges for 2026, including an expected full-year loss. » Más en de.investing.com

Braskem reported Q1 2026 EPS of $0.5059, substantially beating the consensus expectation of -$0.3937. Revenue was $3.15 billion and recurring EBITDA rose 76% quarter‑on‑quarter to $192 million. The stock gained pre‑market (+3.42%); management emphasizes liquidity preservation and working‑capital management. EPS forecasts remain negative for upcoming quarters, and the company cites risks from geopolitical commodity price volatility and high indebtedness. » Más en de.investing.com

Braskem has been informed of the signing of a new shareholders' agreement between Petrobras and the FIP Shine I, which governs joint control of Braskem. The agreement will take effect with a planned share transaction that remains subject to suspensive conditions, including court approvals. Antitrust clearances have already been obtained, and Petrobras has waived pre-emptive and tag-along rights. Braskem's accession to the agreement requires approval by the board of directors; the company intends to inform the market of any material developments. » Más en de.investing.com